Assessment of Medicines for Very Rare Conditions: Review of a New Approach Within the Scottish Medicines Consortium

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.074
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

How Has the SMC Patient and Clinician Engagement (Pace) Process Been Used in Assessments of End-Of-Life Medicines and Medicines to Treat Very Rare Conditions?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

The European Medicines Agency's Approval of New Medicines for Type 2 Diabetes

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Pharmacovigilance of Medicines for Rare and Ultrarare Diseases

Therapeutic Advances in Drug Safety
Pharmacology
2018English

Developing New Medicines for the Treatment of Pain

Prescriber
Pharmacology
2019English

Regulatory Compliance of Herbal Medicines – A Review

International Journal of Research in Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2019English

Fighting Falsified Medicines With Paperwork – A Historic Review of Danish Legislation Governing Distribution of Medicines

Journal of Pharmaceutical Policy and Practice
ToxicologyPharmaceuticsPharmacologyHealth Policy
2016English

Nutraceuticals: New Concept of Medicines

International Journal of Trend in Scientific Research and Development
2018English

A Consortium Approach to Molecular Genetic Services. Scottish Molecular Genetics Consortium.

Journal of Medical Genetics
Genetics
1990English

Review of Anti-Inflammatory Herbal Medicines

Advances in Pharmacological Sciences
ToxicologyMolecular MedicinePharmaceuticsPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy